With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
BenevolentAI (BAI) has three opportunities for biological scientists with experience in leading drug discovery programmes. These individuals, depending on experience, will provide biology leadership of technology-enabled small molecule drug discovery programmes optimising lead compounds into candidates for preclinical development. As a central member of a dynamic, multi-disciplinary team of scientists passionate about the potential of technology assisted drug discovery and development, you will bring your proven resilient leadership and ability to make pragmatic data driven decisions to advance our ever expanding portfolio of small molecule programs. Based at our London offices off Tottenham Court Road, you will work closely with a diverse range of experts in biological sciences, chemical sciences, clinical, commercialisation, artificial intelligence (AI), deep/machine learning (ML) and informatics teams to enrich the BAI portfolio.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI unites AI with human expertise to discover new and more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of over 25 drug programmes. We advance our mission to reinvent drug discovery by harnessing the power of a diverse team, rich with different backgrounds, experiences, opinions and personalities. In our offices in London and New York and research facility in Cambridge (UK), we work in highly collaborative, multidisciplinary teams, harnessing skills across biology, chemistry, engineering, AI, machine learning, informatics, precision medicine and drug discovery.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email firstname.lastname@example.org. Thank you.